Sweden
· Delayed Price · Currency is SEK GUARD Statistics
Total Valuation
Guard Therapeutics International AB has a market cap or net worth of SEK 352.03 million. The enterprise value is 260.45 million.
| Market Cap | 352.03M |
| Enterprise Value | 260.45M |
Important Dates
The next estimated earnings date is Monday, September 2, 2024.
| Earnings Date | Sep 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Guard Therapeutics International AB has 12.06 million shares outstanding. The number of shares has increased by 16.90% in one year.
| Shares Outstanding | 12.06M |
| Shares Change (YoY) | +16.90% |
| Shares Change (QoQ) | +1.87% |
| Owned by Insiders (%) | 16.35% |
| Owned by Institutions (%) | 31.78% |
| Float | 8.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.53 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.30 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.28
| Current Ratio | 5.28 |
| Quick Ratio | 5.23 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10,138.50 |
Financial Efficiency
Return on equity (ROE) is -87.28% and return on invested capital (ROIC) is -56.14%.
| Return on Equity (ROE) | -87.28% |
| Return on Assets (ROA) | -45.41% |
| Return on Capital (ROIC) | -56.14% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -7.17M |
| Employee Count | 11 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +252.66% in the last 52 weeks. The beta is -0.09, so Guard Therapeutics International AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +252.66% |
| 50-Day Moving Average | 29.10 |
| 200-Day Moving Average | 27.68 |
| Relative Strength Index (RSI) | 51.47 |
| Average Volume (20 Days) | 2,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.11M |
| Pretax Income | -78.82M |
| Net Income | -78.82M |
| EBITDA | -81.09M |
| EBIT | -81.11M |
| Earnings Per Share (EPS) | -7.80 |
Balance Sheet
| Cash & Cash Equivalents | 91.59M |
| Total Debt | n/a |
| Net Cash | 91.59M |
| Net Cash Per Share | 7.60 |
| Equity (Book Value) | 74.94M |
| Book Value Per Share | 6.45 |
| Working Capital | 75.43M |
Cash Flow
| Operating Cash Flow | -80.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Guard Therapeutics International AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.90% |
| Shareholder Yield | -16.90% |
| Earnings Yield | -26.70% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 15, 2023. It was a reverse split with a ratio of 0.02.
| Last Split Date | Dec 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.02 |